Skip to content

A prospective, non-randomized, clinical study evaluating MR with volunteers

Philips Magnetic Resonance Study Protocol — Human Volunteer Scanning for System Feasibility, Optimization, Demonstration and Education

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/06/025595
Enrollment
300
Registered
2020-06-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Philips India Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Volunteeris willing and capable of providing informed consent and physically capable of performing study related activities. 2) Volunteer age between 18 -65 years old including either sex. 3) Volunteer has passed a general medical health check which involves laboratory investigations like CBC, ESR,RBS, Serum Creatinine, HIV, HbsAg, HCV, Urine analysis, ECG and UPT( for child bearing potential female subjects only).

Exclusion criteria

Exclusion criteria: 1) Volunteers with any known contraindications for MR scanning 2) Volunteers with Pacemakers or other implanted electronic devices which are Non MR Compatible 3) Volunteers with metal implants which are not MR conditional or MR safe 4) Volunteers with small metal components in the body (vascular clips, metal splinters, stents, etc.) which are not MR conditional or MR safe 5) Volunteers with epilepsy 6) Volunteer with known severe cardiac disorders, Cerebrovascular, Respiratory, Hepatic, Renal, or Congenital anomaly or any other conditions as per the Physician opinion 7) Volunteers with uncontrolled hyper tension and diabetic Mellitus 8) Volunteers with dermal medicinal patches 9) Volunteers with mental illness or diseases, known claustrophobia, anxiety or panic disorders 10) Volunteers with Meniere’s disease or any previous history of tinnitis 11) Pregnant women 12) Volunteers with significant chronic illness

Design outcomes

Primary

MeasureTime frame
There is no formal endpoint, as the study is not being conducted to test for safety and efficacy.Timepoint: There is no formal endpoint, as the study is not being conducted to test for safety and efficacy.

Secondary

MeasureTime frame
There is no formal endpoint, as the study is not being conducted to test for safety and efficacy.Timepoint: There is no formal endpoint, as the study is not being conducted to test for safety and efficacy.

Countries

India

Contacts

Public ContactMrHasan Ali

Philips India Limited,

alagammai.ramanathan@philips.com08884722789

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026